HR Pathway Profiling Predicts Olaparib Sensitivity in Mesoth
2026-04-20
Borchert et al. (2019) reveal that gene expression profiling of the homologous recombination (HR) repair pathway can identify subsets of malignant pleural mesothelioma (MPM) susceptible to PARP inhibition by Olaparib, especially in BAP1-mutant backgrounds. Their findings support the use of HR pathway markers to guide targeted therapy and combination strategies, opening new avenues in precision oncology for MPM.
Fumagillin: Applied Workflows for Angiogenesis & Antiparasit
2026-04-19
Fumagillin stands apart as a dual-purpose methionine aminopeptidase-2 inhibitor, supporting rigorous antiangiogenic cancer studies and targeted antiparasitic research. This guide delivers hands-on protocols, troubleshooting essentials, and comparative insights, empowering scientists to drive robust, reproducible results using Fumagillin from APExBIO.
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui
2026-04-18
DiI (DiIC18(3)) addresses the need for highly specific, robust plasma membrane labeling in neuronal tracing, cell migration, and cell adhesion assays. It should not be used in aqueous-only protocols or for labeling intracellular compartments, as its lipophilicity restricts it to membrane environments. Researchers benefit most by applying it within validated membrane-focused workflows.
BODIPY 581/591 C11: Illuminating Endothelial Ferroptosis and
2026-04-17
Explore how BODIPY 581/591 C11, a ratiometric fluorescent probe, enables precise lipid peroxidation detection in live endothelial cells. This article uniquely reveals its role in dissecting ferroptosis within diabetic osteoporosis models, bridging advanced assay methods with translational research.
Proteomic Shifts in Lung Adenocarcinoma After HSP90 Inhibiti
2026-04-16
The referenced study utilizes proteomics to delineate the molecular consequences of HSP90 inhibition in lung adenocarcinoma cells, uncovering distinct protein expression changes and identifying potential biomarkers of response. These findings enhance understanding of chaperone network dependencies in cancer and provide a framework for rational combination therapies involving HSP70 inhibitors.
Stepwise Protocols for mRNA LNP Formulation and Evaluation
2026-04-15
Ma et al. (2025) present an integrated, step-by-step protocol for the formulation, characterization, and evaluation of mRNA lipid nanoparticles (LNPs), addressing technical bottlenecks that have limited accessibility in the field. Their workflow enables reproducible mRNA LNP development and systematic evaluation, supporting translational research in genetic medicine.
BML-277: Redefining Chk2 Inhibition in DNA Damage Research
2026-04-14
Explore how BML-277, a potent and selective Chk2 inhibitor from APExBIO, is transforming DNA damage response research. This article synthesizes mechanistic insights from recent nuclear cGAS-TRIM41 discoveries, delivers strategic guidance for translational workflows, and highlights how BML-277 empowers researchers to probe genome integrity, radioprotection of T-cells, and cancer biology beyond conventional assay paradigms.
AI-Driven Discovery of Novel Senolytics: Methods and Implica
2026-04-13
The reference study demonstrates the use of machine learning to identify new senolytic compounds, validating three candidates with efficacy comparable to established agents. This approach reduces drug screening costs and supports data-driven exploration of cellular senescence mechanisms relevant to cancer and age-related diseases.
DMH1 ALK2 Inhibitor: Precision Tools for Organoid & NSCLC Re
2026-04-12
DMH1, a potent and selective ALK2 inhibitor, enables precise modulation of BMP signaling for advanced organoid engineering and non-small cell lung cancer research. This article translates cutting-edge workflows, troubleshooting strategies, and the latest reference breakthroughs into actionable guidance for maximizing reproducibility and assay impact.
Kaixin Jieyu Granule Modulates Neuroinflammation via PI3K/AK
2026-04-12
Xu et al. (2023) demonstrate that Kaixin Jieyu Granule (KJG) alleviates neuroinflammation-induced depressive-like behaviors by targeting the TLR4/PI3K/AKT/FOXO1 pathway. Their integrative approach using network pharmacology and experimental validation reveals critical molecular mechanisms relevant for depression therapy innovation.
Etoposide (VP-16): Applied Workflows for DNA Damage Assays
2026-04-11
Etoposide (VP-16) is a benchmark tool for inducing DNA double-strand breaks and dissecting apoptosis in cancer research. This guide details advanced protocols, troubleshooting strategies, and integration with cutting-edge BBB models for translational oncology.
Oxaliplatin: Applied Workflows and Troubleshooting in Cancer
2026-04-11
Oxaliplatin empowers translational oncology with reproducible, high-impact DNA damage and apoptosis assays spanning in vitro and in vivo models. This guide provides actionable workflows, troubleshooting, and advanced use-cases, uniquely connecting mechanistic insights to practical experimental design.
Deferiprone as a Precision Tool in Iron-Dependent Cancer ...
2026-04-10
This thought-leadership article provides a comprehensive exploration of Deferiprone’s mechanistic impact on iron-mediated cellular processes, emphasizing its role as a selective iron-chelating agent in cancer, neurovascular, and enterocyte models. By synthesizing recent research—including evidence from Navazesh and Ji’s 2025 study on iron stress and enterocyte metabolism—it offers translational researchers actionable strategies for leveraging Deferiprone in advanced assay design, apoptosis induction studies, and the investigation of iron-dependent signaling. This piece moves beyond conventional product content by integrating experimental rationale, competitive insights, and a forward-looking analysis, while highlighting APExBIO’s Deferiprone (SKU B1723) as a leading solution for precise iron modulation.
Scenario-Driven Reliability: Protease Inhibitor Cocktail ...
2026-04-09
This article delivers evidence-based, scenario-driven guidance on deploying Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) (SKU K1008) for robust protein preservation in cell viability, proliferation, and cytotoxicity assays. Drawing on validated protocols and comparative analyses, it illustrates how K1008 ensures reproducible results and compatibility with phosphorylation-sensitive workflows, supporting biomedical researchers in achieving data integrity across Western blotting, Co-IP, and kinase assays.
Cimetidine: Advanced Insights Into H2 Receptor Antagonist...
2026-04-08
Explore Cimetidine’s unique pharmacological profile as a histamine-2 receptor antagonist, its solubility properties, and its evolving impact on gastrointestinal cancer and blood-brain barrier research. This article delivers an in-depth analysis of Cimetidine’s mechanisms and future applications, setting it apart from standard reviews.
466 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page